From January 1, 2022 to January 19, 2022, the company has repurchased 0 shares, representing 0% for CNY 0 million. With this, the company has completed the repurchase of 2,273,523 shares, representing 1.44% for CNY 79.31 million under the buyback announced on January 21, 2021.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
30.57 CNY | +1.33% | -4.26% | -19.72% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-19.72% | 664M | |
+32.10% | 694B | |
+29.39% | 593B | |
-1.54% | 371B | |
+20.10% | 331B | |
+7.10% | 290B | |
+14.25% | 239B | |
-3.03% | 209B | |
+10.02% | 209B | |
+8.41% | 169B |
- Stock Market
- Equities
- 603590 Stock
- News Beijing Konruns Pharmaceutical Co.,Ltd.
- Tranche Update on Beijing Konruns Pharmaceutical Co.,Ltd.'s Equity Buyback Plan announced on January 21, 2021.